Healthy volunteers help uncover drug interaction risks for ZX008
NCT ID NCT06679413
First seen Apr 25, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study looked at how a new drug called ZX008 affects the way the body processes three other common drugs (midazolam, bupropion, and metformin) in 22 healthy adults aged 18 to 55. Participants took the three drugs alone first, then again after receiving ZX008. The goal was to measure changes in drug levels in the blood and check for side effects. This is a phase 1 drug-drug interaction study, not a treatment for any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY STUDY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Up0132 1001
Baltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.